The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice
- 18 October 2002
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 9 (11), 908-916
- https://doi.org/10.1038/sj.cgt.7700519
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Renal cell carcinomaCurrent Opinion in Oncology, 2001
- Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactionsCancer Gene Therapy, 2000
- Surgical pathology of renal epithelial neoplasms: recent advances and current statusHistopathology, 2000
- Follow‐up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomyBJU International, 1999
- Double Suicide Gene (Cytosine Deaminase and Herpes Simplex Virus Thymidine Kinase) but Not Single Gene Transfer Allows Reliable Elimination of Tumor CellsIn VivoHuman Gene Therapy, 1998
- Gene therapyCurrent Biology, 1998
- Mechanisms of angiogenesisNature, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- New perspectives in clinical oncology from angiogenesis researchEuropean Journal of Cancer, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995